SCHEMBL26051138

SCHEMBL26051138

CC(C)CNc1cc(C(=O)NCCN(C)C)c(Oc2ccc(F)cc2F)cc1C=N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.56
▸ BRD4 O60885 1/20 0.41
▸ ACKR3 P25106 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ RAD52 P43351 2/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ CSF1R P07333 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18359310 0.74 PTGS2 (0.34) MAPK14BRD4KMT2AL3MBTL1MEN1
Arry-797 SCHEMBL29349798 0.72 MAPK14 (1.00) MAPK14BRD4ACKR3KMT2AL3MBTL1
SCHEMBL31371662 0.72 MAPK14 (0.69) MAPK14BRD4ACKR3SMN1; SMN2ALDH1A1
Arry-797 SCHEMBL31046796 0.72 MAPK14 (1.00) MAPK14BRD4ACKR3KMT2AL3MBTL1
Arry-797 SCHEMBL222635 0.72 MAPK14 (1.00) MAPK14BRD4ACKR3KMT2AL3MBTL1
Arry-797 SCHEMBL29351662 0.72 MAPK14 (1.00) MAPK14BRD4ACKR3KMT2AL3MBTL1
SCHEMBL31371546 0.71 MAPK14 (0.61) MAPK14BRD4ACKR3KMT2AL3MBTL1
SCHEMBL21038023 0.71 MAPK14 (0.61) MAPK14BRD4ACKR3KMT2AL3MBTL1
SCHEMBL30231342 0.71 ACKR3 (0.69) MAPK14ACKR3L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL31371686 0.71 MAPK14 (0.85) MAPK14BRD4ACKR3SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263803-A1 METHODS OF PREVENTING OR TREATING COVID-19 AND RELATED VIRAL DISEASES OR DISORDERS KINARUS AG (CH) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263803-A1 METHODS OF PREVENTING OR TREATING COVID-19 AND RELATED VIRAL DISEASES OR DISORDERS PPARA, PPARD, PPARG MAPK14 85/4885BRD4 365/4885ACKR3 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback